NeuroPace's three largest insider shareholders as of September 29, 2026 are Partners Ii L.P. Accelmed (TenPercentOwner, 4.43Mn shares), Advisors Llc Orbimed (TenPercentOwner, 3.24Mn shares), Frank M Fischer (Director, 599.53K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Partners Ii L.P. Accelmed | TenPercentOwner | 4,432,948 | 0 | 4,432,948 | 47.6% | 23 Nov, 2022 |
| 2 | Advisors Llc Orbimed | TenPercentOwner | 0 | 3,238,199 | 3,238,199 | 34.8% | 16 May, 2025 |
| 3 | Frank M Fischer | Director | 599,534 | 0 | 599,534 | 6.4% | 22 Jun, 2026 |
| 4 | Michael Favet | Chief Executive Officer | 407,080 | 0 | 407,080 | 4.4% | 22 Feb, 2023 |
| 5 | Irina Ridley | Chief Legal Officer/Secretary | 141,139 | 0 | 141,139 | 1.5% | 22 Feb, 2023 |
| 6 | Joel Becker | Chief Executive Officer | 138,000 | 0 | 138,000 | 1.5% | 04 Sep, 2026 |
| 7 | Rebecca Kuhn | Chief Financial Officer | 131,613 | 0 | 131,613 | 1.4% | 06 Jun, 2025 |
| 8 | Martha Morrell | Chief Medical Officer | 95,603 | 0 | 95,603 | 1.0% | 25 Sep, 2026 |
| 9 | Patrick F. Williams | Chief Financial Officer | 67,508 | 0 | 67,508 | 0.7% | 21 Sep, 2026 |
| 10 | Rakhi Kumar | Director | 23,039 | 0 | 23,039 | 0.2% | 22 Jun, 2026 |
| 11 | Uri Geiger | Director | 18,537 | 0 | 18,537 | 0.2% | 22 Jun, 2026 |
| 12 | Joseph Lacob | Director | 14,754 | 0 | 14,754 | 0.2% | 24 Mar, 2026 |
| 13 | Renee Ryan | Director | 2,890 | 0 | 2,890 | 0.0% | 05 Jun, 2026 |
| 14 | Lisa Andrade | Director | 2,890 | 0 | 2,890 | 0.0% | 05 Jun, 2026 |
| 15 | R Scott Huennekens | Director | 2,890 | 0 | 2,890 | 0.0% | 05 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 24 Sep, 2026 | Martha Morrell | Chief Medical Officer | Disposed F | 335 | $13.97 | $4.68K | 51,357 | Direct |
| 20 Sep, 2026 | Patrick F. Williams | Chief Financial Officer | Disposed F | 1,162 | $14.28 | $16.59K | 67,508 | Direct |
| 03 Sep, 2026 | Joel Becker | Chief Executive Officer | Disposed F | 1,310 | $14.75 | $19.32K | 138,000 | Direct |
| 27 Aug, 2026 | Martha Morrell | Chief Medical Officer | Disposed F | 358 | $14.13 | $5.06K | 51,692 | Direct |
| 27 Aug, 2026 | Joel Becker | Chief Executive Officer | Disposed F | 1,126 | $14.13 | $15.91K | 139,310 | Direct |
| 24 Jun, 2026 | Martha Morrell | Chief Medical Officer | Disposed F | 335 | $16.22 | $5.43K | 52,050 | Direct |
| 19 Jun, 2026 | Uri Geiger | Director | Acquired A | 789 | $15.63 | $12.33K | 18,537 | Direct |
| 19 Jun, 2026 | Rakhi Kumar | Director | Acquired A | 989 | $15.63 | $15.46K | 23,039 | Direct |
| 19 Jun, 2026 | Frank M Fischer | Director | Acquired A | 1,467 | $15.63 | $22.93K | 599,534 | Direct |
| 05 Jun, 2026 | R Scott Huennekens | Director | Acquired A | 2,890 | $0.00 | $0 | 2,890 | Direct |
| 05 Jun, 2026 | Renee Ryan | Director | Acquired A | 2,890 | $0.00 | $0 | 2,890 | Direct |
| 05 Jun, 2026 | Uri Geiger | Director | Acquired A | 2,890 | $0.00 | $0 | 17,748 | Direct |
| 05 Jun, 2026 | Frank M Fischer | Director | Acquired A | 2,890 | $0.00 | $0 | 598,067 | Direct |
| 05 Jun, 2026 | Rakhi Kumar | Director | Acquired A | 2,890 | $0.00 | $0 | 22,050 | Direct |
| 05 Jun, 2026 | Lisa Andrade | Director | Acquired A | 2,890 | $0.00 | $0 | 2,890 | Direct |
| 05 Jun, 2026 | Lisa Andrade | Director | Acquired A | 5,368 | $0.00 | $0 | 5,368 | Direct |
| 05 Jun, 2026 | Renee Ryan | Director | Acquired A | 5,368 | $0.00 | $0 | 5,368 | Direct |
| 05 Jun, 2026 | Frank M Fischer | Director | Acquired A | 5,368 | $0.00 | $0 | 5,368 | Direct |
| 05 Jun, 2026 | Rakhi Kumar | Director | Acquired A | 5,368 | $0.00 | $0 | 5,368 | Direct |
| 05 Jun, 2026 | R Scott Huennekens | Director | Acquired A | 5,368 | $0.00 | $0 | 5,368 | Direct |